🇺🇸 FDA
Patent

US 6166079

DFMO for the treatment or prevention of cervical intraepithelial neoplasia

expired A61KA61K31/195A61K31/198

Quick answer

US patent 6166079 (DFMO for the treatment or prevention of cervical intraepithelial neoplasia) held by The Board of Regents of the University of Texas System expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/195, A61K31/198